Visfatin - A review

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 1, 2011, Pages 9-14

  Sonoli, Smita S ^a   Shivprasad, S ^a   Prasad, C V B ^a   Patil, A B ^a   Desai, P B ^a   Somannavar, M S ^a  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

Author keywords

Adipokines; Nampt; PBEF; Visfatin

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ADIPOCYTOKINE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE RIBOSIDE KINASE; PHOSPHOTRANSFERASE; RECOMBINANT INTERLEUKIN 1ALPHA; SILENT INFORMATION REGULATOR PROTEIN 2; SIRTUIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; AMINO ACID SEQUENCE; APOPTOSIS; BLOOD BRAIN BARRIER; BODY MASS; BONE METABOLISM; CEREBROSPINAL FLUID; CYTOPLASM; DIABETES MELLITUS; DRUG ACTIVITY; DRUG BINDING; ENTERITIS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS MEMBRANE; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MALE; NEUTROPHIL; NONHUMAN; OBESITY; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; REVIEW; RHEUMATOID ARTHRITIS; SUBCUTANEOUS FAT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; BLOOD; BONE; CHEMISTRY; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BODY MASS INDEX; BONE AND BONES; HUMANS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY;

EID: 79953129992     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. FLIER JS, FLIER EM. Biology of Obesity. In: Harrison's Principles of Internal Medicine (Wiener C, Fauci A S, Braunwald E, Kasper D, Hauser SI, Longo D I et al, eds). The Mcgraw-Hill companies Inc, New York, 2007; pp. pp. 462-472.
2. SAMAL B, SUN Y, STEARNS G, XIE C, SUGGS S, MCNIECE I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14: 1431-1437.
3. FUKUHARA A, MATSUDA M, NISHIZAWA M, SEGAWA K, TANAKA M, KISHIMOTO K, MATSUKI Y, MURAKAMI M, ICHISAKA T, MURAKAMI H, WATANABE E, TAKAGI T, AKIYOSHI M, OHTSUBO T, KIHARA S, YAMASHITA S, MAKISHIMA M, FUNAHASHI T, YAMANAKA S, HIRAMATSU R, MATSUZAWA Y, SHIMOMURA I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
4. WANG T, ZHANG X, BHEDA P, REVOLLO JR, IMAI S, WOLBERGER C. Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nat Struct Mol Biol 2006; 13: 661-662.
5. KIM MK, LEE JH, KIM H, PARK SJ, KIM SH, KANG GB, LEE YS, KIM JB, KIM KK, SUH SW, EOM SH. Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866. Mol Biol 2006; 362: 66-77.
6. JIA SH, LI Y, PARODO J, KAPUS A, FAN L, ROTSTEIN OD, MARSHALL JC. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318-1327.
7. ADEGHATE E. Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr Med Chem 2008; 15: 1851-1862.
8. OGNJANOVIC S, BAO S, YAMAMOTO SY, GARIBAY-TUPAS J, SAMAL B, BRYANT-GREENWOOD GD. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001; 26: 107-117.
9. MOSCHEN AR, KASER A, ENRICH B, MOSHEIMER B, THEURL M, NIEDEREGGER H, TILG H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178: 1748-1758.
10. OTERO M, LAGO R, GOMEZ R, LAGO F, DIEGUEZ C, GÓMEZ-REINO JJ, GUALILLO O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1198-1201.
11. YE SQ, SIMON BA, MALONEY JP, ZAMBELLI-WEINER A, GAO L, GRANT A, EASLEY R B, MCVERRY BJ, TUDER RM, STANDIFORD T, BROWER RG, BARNES KC, GARCIA JG. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005; 171: 361-370.
12. KOCZAN D, GUTHKE R, THIESEN HJ, IBRAHIM SM, KUNDT G, KRENTZ H, GROSS G, KUNZ M. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 2005; 15: 251-257.
13. REVOLLO JR, GRIMM AA, IMAI S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007; 23: 164-170.
14. ZIEGLER M. New functions of a long-known molecule, emerging roles of NAD in cellular signaling. Eur J Biochem 2000; 267: 1550-1564.
15. MICHAN S, SINCLAIR D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404, 1-13.
16. GRUBISHA O, SMITH BC, DENU JM. Small molecule regulation of Sir2 protein deacetylases. FEBS J 2005; 272: 4607-4616.
17. VAN DER VEER E, HO C, O'NEIL C, BARBOSA N, SCOTT R, CREGAN SP, PICKERING JG. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem 2007; 282: 10841-10845.
18. HAIDER DG, SCHALLER G, KAPIOTIS S, MAIER C, LUGER A, WOLZT M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49: 1909-1914.
19. HAIDER DG, PLEINER J, FRANCESCONI M, WIESINGER GF, MÜLLER M, WOLZT M. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab 2006; 91: 4702-4704.
20. DOGRU T, SONMEZ A, TASCI I, BOZOGLU E, YILMAZ MI, GENC H, ERDEM G, GOK M, BINGOL N, KILIC S, OZGURTAS T, BINGOL S. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007; 76: 24-29.
21. LÓPEZ-BERMEJO A, CHICO-JULIÀ B, FERNANDEZ-BALSELLS M, RECASENS M, ESTEVE E, CASAMITJANA R, RICART W, FERNANDEZ-REAL JM. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006; 55: 2871-2875.
22. KRZYZANOWSKA K, KRUGLUGER W, MITTERMAYER F, RAHMAN R, HAIDER D, SHNAWA N, SCHERNTHANER G. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 2006; 110: 605-609.
23. LEWANDOWSKI KC, STOJANOVIC N, PRESS M, TUCK SM, SZOSLAND K, BIENKIEWICZ M, VATISH M, LEWINSKI A, PRELEVIC GM, RANDEVA HS. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007; 50: 1033-1037.
24. BERNDT J, KLÖTING N, KRALISCH S, KOVACS P, FASSHAUER M, SCHÖN MR, STUMVOLL M, BLÜHER M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54: 2911-2916.
25. FUKUHARA A, MATSUDA M, NISHIZAWA M, SEGAWA K, TANAKA M, KISHIMOTO K, MATSUKI Y, MURAKAMI M, ICHISAKA T, MURAKAMI H, WATANABE E, TAKAGI T, AKIYOSHI M, OHTSUBO T, KIHARA S, YAMASHITA S, MAKISHIMA M, FUNAHASHI T, YAMANAKA S, HIRAMATSU R, MATSUZAWA Y, SHIMOMURA I. Retraction Science 2007; 318: 565.
26. REVOLLO JR, KORNER A, MILLS KF, SATOH A, WANG T, GARTEN A, DASGUPTA B, SASAKI Y, WOLBERGER C, TOWNSEND RR, MILBRANDT J, KIESS W, IMAI S. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007; 6: 363-375.
27. SAVILL JS, WYLLIE AH, HENSON JE, WALPORT MJ, HENSON PM, HASLETT C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865-875.
28. JIMENEZ MF, WATSON RW, PARODO J, EVANS D, FOSTER D, STEINBERG M, ROTSTEIN OD, MARSHALL JC. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997; 132: 1263-1270.
29. DEDOUSSIS GV, KAPIRI A, SAMARA A, DIMITRIADIS D, LAMBERT D, PFISTER M, SIEST G, VISVIKIS-SIEST S. Visfatin: the link between inflammation and childhood obesity. Diabetes Care 2009; 32: e71.
30. MANCO M, FERNANDEZ-REAL JM, EOUITANI F, VENDRELL J, VALERA MORA ME, NANNI G, TONDOLO V, CALVANI M, RICART W, CASTAGNETO M, MINGRONE G. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 2007; 92: 483-490.
31. HAIDER DG, SCHINDLER K, SCHALLER G, PRAGER G, WOLZT M, LUDVIK B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006; 91: 1578-1581.
32. AXELSSON J, WITASP A, CARRERO JJ, QURESHI A R, SULIMAN M E, HEIMBÜRGER O & BÁRÁNY P, LINDHOLM B, ALVESTRAND A, SCHALLING M, NORDFORS L, STENVINKEL P. (2007) Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007; 49: 237-244
33. NÜSKEN KD, PETRASCH M, RAUH M, STÖHR W, NÜSKEN E, SCHNEIDER H, DÖTSCH J. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol. Nephrol Dial Transplant. 2009; 24: 2832-2838.
34. YILMAZ MI, SAGLAM M, CARRERO JJ, QURESHI AR, CAGLAR K, EYILETEN T, SONMEZ A, CAKIR E, YENICESU M, LINDHOLM B, STENVINKEL P, AXELSSON J. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant 2008; 23: 959-965.
35. XIE H, TANG SY, LUO XH, HUANG J, CUI RR, YUAN LQ, ZHOU HD, WU XP, LIAO EY. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007; 80: 201-210.
36. MOSCHEN AR, GEIGER S, GERNER R, TILG H. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat Res 2009; Jul 5. [Epub ahead of print]
37. HALLSCHMID M, RANDEVA H, TAN BK, KERN W, LEHNERT H. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 2009; 58: 637-640.
38. KÖRNER A, GARTEN A, BLÜHER M, TAUSCHER R, KRATZSCH J, KIESS W. Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 2007; 92: 4783-4791.
39. CHEN MP, CHUNG FM, CHANG DM, TSAI JC, HUANG HF, SHIN SJ, LEE YJ. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 295-299.